MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

Intuitive Surgical Inc

Suletud

SektorTervishoid

495.8 0.17

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

486

Max

496.79

Põhinäitajad

By Trading Economics

Sissetulek

123M

688M

Müük

374M

2.4B

P/E

Sektori keskmine

76.905

63.778

Aktsiakasum

2.21

Kasumimarginaal

28.506

Töötajad

15,638

EBITDA

116M

810M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+29.31% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

22. apr 2025

Turustatistika

By TradingEconomics

Turukapital

-30B

177B

Eelmine avamishind

495.63

Eelmine sulgemishind

495.8

Uudiste sentiment

By Acuity

36%

64%

118 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Intuitive Surgical Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. jaan 2025, 21:41 UTC

Tulu

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21. jaan 2025, 18:37 UTC

Omandamised, ülevõtmised, äriostud

Intuitive to Establish Direct Presence in Europe With Acquisition

18. okt 2024, 15:22 UTC

Tulu
Suurimad hinnamuutused turgudel

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

17. okt 2024, 21:33 UTC

Tulu
Suurimad hinnamuutused turgudel

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17. okt 2024, 20:56 UTC

Tulu

Intuitive Surgical Posts 3Q Revenue Growth

24. jaan 2025, 21:17 UTC

Tulu

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24. jaan 2025, 18:18 UTC

Tulu

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24. jaan 2025, 13:11 UTC

Peamised uudised

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24. jaan 2025, 09:51 UTC

Kuumad aktsiad

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23. jaan 2025, 21:10 UTC

Tulu

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23. jaan 2025, 21:09 UTC

Tulu

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23. jaan 2025, 21:09 UTC

Tulu

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Rev $2.41B >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Net $685.7M >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q EPS $1.88 >ISRG

15. jaan 2025, 17:27 UTC

Tulu

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

6. jaan 2025, 12:00 UTC

Peamised uudised

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

18. okt 2024, 15:59 UTC

Tulu

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

18. okt 2024, 15:38 UTC

Tulu

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

18. okt 2024, 13:28 UTC

Tulu

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

17. okt 2024, 21:18 UTC

Tulu
Suurimad hinnamuutused turgudel

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

17. okt 2024, 20:22 UTC

Tulu

Intuitive Surgical Adds To 41% Run With Massive Profit Beat, Strong Procedure Growth -- IBD

17. okt 2024, 20:05 UTC

Tulu

Intuitive Surgical 3Q Adj EPS $1.84 >ISRG

17. okt 2024, 20:05 UTC

Tulu

Intuitive Surgical 3Q Rev $2.04B >ISRG

17. okt 2024, 20:05 UTC

Tulu

Intuitive Surgical 3Q EPS $1.56 >ISRG

17. okt 2024, 20:05 UTC

Tulu

Intuitive Surgical 3Q Net $565.1M >ISRG

19. juuli 2024, 13:50 UTC

Uudisväärsed sündmused

Dow Jones, Other Indexes Open Lower As Global Outage Hits Many Companies; Netflix Climbs After Earnings -- IBD

19. juuli 2024, 13:10 UTC

Uudisväärsed sündmused

Dow Jones Futures Lower, S&P Higher As Global Outage Hits Many Companies; Netflix Climbs After Earnings -- IBD

Võrdlus sarnastega

Hinnamuutus

Intuitive Surgical Inc Prognoos

Hinnasiht

By TipRanks

29.31% tõus

12 kuu keskmine prognoos

Keskmine 641.83 USD  29.31%

Kõrge 711 USD

Madal 570 USD

Põhineb 22 Wall Streeti analüütiku instrumendi Intuitive Surgical Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

22 ratings

16

Osta

6

Hoia

0

Müü

Tehniline skoor

By Trading Central

492.06 / 508.58Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Weak Bullish Evidence

Sentiment

By Acuity

118 / 386 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.